Cancer Stem Cell News Volume 2.05 | Feb 6 2013


    Cancer Stem Cell News 2.05 February 6, 2013
         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  Cancer Stem Cell News on Twitter

    Blood Vessel Cells Coax Colorectal Cancer Cells into More Dangerous State
    Working in human colorectal cancer cell lines and tumor samples, as well as mouse models, researchers found that endothelial cells can trigger changes in cancer cells without even coming into direct contact with them. This signaling by the endothelial cells causes colorectal cancer cells to take on the attributes of cancer stem cells. [Press release from The University of Texas MD Anderson Cancer Center discussing online prepublication in Cancer Cell] Press Release | Abstract | Graphical Abstract

    [Watch the Video] Detect Cancer Stem Cells with ALDEFLUOR™.

    PUBLICATIONS (Ranked by impact factor of the journal)

    Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
    Epithelial-mesenchymal transition (EMT) of adherent epithelial cells to a migratory mesenchymal state has been implicated in tumor metastasis in preclinical models. To investigate its role in human cancer, researchers characterized EMT in circulating tumor cells from breast cancer patients. [Science]
    Abstract | Press Release

    Expression of Intercellular Adhesion Molecule-1 by Hepatocellular Carcinoma Stem Cells and Circulating Tumor Cells
    Intercellular adhesion molecule-1 (ICAM1) is believed to be involved in metastasis of hepatocellular carcinoma (HCC) cells. Researchers investigated whether ICAM1 is a marker of HCC stem cells. [Gastroenterology] Abstract

    miR-7 Suppresses Brain Metastasis of Breast Cancer Stem-Like Cells by Modulating KLF4
    Scientists found that cancer stem-like cells (CSCs) (CD24/CD44+/ESA+) isolated from metastatic breast cell lines are significantly more metastatic than non-CSC populations in an organ-specific manner. [Cancer Res] Abstract | Press Release

    A CD90+ Tumor-Initiating Cell Population with an Aggressive Signature and Metastatic Capacity in Esophageal Cancer
    Researchers report a CD90+ cell population found in esophageal squamous cell carcinoma which is endowed with stem cell-like properties and high tumorigenic and metastatic potential. [Cancer Res] Abstract

    Lmo2 Induces Hematopoietic Stem Cell Like Features in T-Cell Progenitor Cells Prior to Leukemia
    LIM domain Only 2 (Lmo2) is frequently deregulated in sporadic and gene therapy-induced acute T-cell lymphoblastic leukemia where its overexpression is an important initiating mutational event. Researchers analyzed proliferation, differentiation, and cell death in CD2-Lmo2 transgenic thymic progenitor cells to understand the cellular effects of enforced Lmo2 expression. [Stem Cells] Abstract

    Resistance to DNA-Damaging Treatment in Non-Small Cell Lung Cancer Tumor-Initiating Cells Involves Reduced DNA-PK/ATM Activation and Diminished Cell Cycle Arrest
    Increasing evidence suggests that tumor-initiating cells, also called cancer stem cells, are partly responsible for resistance to DNA-damaging treatment. Researchers addressed if such a phenotype may contribute to radio- and cisplatin resistance in non-small cell lung cancer. [Cell Death Dis] Full Article

    Peroxisome Proliferator Activated Receptor-α/Hypoxia Inducible Factor-1α Interplay Sustains Carbonic Anhydrase IX and Apoliprotein E Expression in Breast Cancer Stem Cells
    Investigators report on the relationship between nuclear receptors activity and the modulation of the pro-inflammatory phenotype in breast cancer stem cells. [PLoS One] Full Article

    Evaluation of Characteristics of CD44+CD117+ Ovarian Cancer Stem Cells in Three Dimensional Basement Membrane Extract Scaffold versus Two Dimensional Monocultures
    The authors demonstrated that human epithelial ovarian cancer CD44+CD117+ cells possessed the properties of cancer stem cells that exhibited more chemoresistance in the three-dimensional culture than that of in two-dimensional one. [BMC Cell Biol] Full Article

    NeuroCult™ for Brain Tumor Research - View Publications

    Nanotheranostics of Circulating Tumor Cells, Infections and Other Pathological Features In Vivo
    This article reviews novel therapeutic and diagnostic (theranostic) platforms integrating in vivo real-time early diagnosis of circulating tumor cells, circulating endothelial cells, circulating bacterial cells and other abnormal objects in circulation. This critical review particularly focuses on nanotechnology-based theranostic (nanotheranostic) approaches, especially in vivo photoacoustic and photothermal nanotheranostic platforms. [Mol Pharm] Abstract


    Stem Cell Therapeutics Announces Agreement with Trillium Therapeutics Inc. for Merger
    Stem Cell Therapeutics Corp. announced the execution of a Letter of Agreement with Trillium Therapeutics Inc. of Toronto, under which Trillium would be merged into Stem Cell Therapeutics Corp. (SCT) by way of a three-cornered amalgamation or plan of arrangement with a newly-created SCT subsidiary. [Stem Cell Therapeutics Corp.] Press Release

    ImmunoCellular Therapeutics’ Investigational New Drug (IND) Application for ICT-140 Allowed by the FDA
    ImmunoCellular Therapeutics, Ltd. announced that the US Food and Drug Administration (FDA) has allowed the IND application for ICT-140, paving the way for conducting a clinical trial. ICT-140 is a dendritic cell vaccine targeting seven antigens that are over-expressed in ovarian cancer, as well as cancer stem cells. [ImmunoCellular Therapeutics, Ltd.] Press Release

    Verastem Initiates Phase I/Ib Clinical Trial of VS-6063 Plus Paclitaxel for Patients with Ovarian Cancer
    Verastem, Inc. announced the initiation of a Phase I/Ib trial of VS-6063 in combination with paclitaxel for the treatment of advanced ovarian cancer. [Verastem, Inc.] Press Release

    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)


    NEW Danish Stem Cell Society (DASCS) 2nd Symposium 2013
    March 7, 2013
    Copenhagen, Denmark

    NEW Cell Reprogramming Australia (CRA) – Frontiers in Cell Reprogramming
    May 6-7, 2013
    Brisbane, Australia

    our events page to see a complete list of events in the cancer stem cell community.


    Postdoctoral Fellow – Cancer Biology and Stem Cell (University of Texas at Houston, Medical School)

    Postdoctoral Fellow – Myeloproliferative Neoplasms (Mount Sinai Medical Center)

    Postdoctoral Scientist – Defining and Targeting Leukemic Stem Cells in Acute Leukemia (University of Oxford)

    Postdoctoral Fellow – Breast Cancer Stem Cells (University of Cincinnati College of Medicine)

    Faculties in Cancer Biology & Immunotherapy (Huzhou University School of Medicine)

    Faculty Position – Mammalian Epigenetics and Genome Biology (Cornell University)

    Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

    Have we missed an important article or publication in Cancer Stem Cell News? Click here to submit!

    Comments or Suggestions? Email with your feedback.

    Learn more about Cancer Stem Cell News: Archives | Events | Contact Us